Authors:
Cabelguenne, A
Loriot, MA
Stucker, I
Blons, H
Koum-Besson, E
Brasnu, D
Beaune, P
Laccourreye, O
Laurent-Puig, P
De Waziers, I
Citation: A. Cabelguenne et al., Glutathione-associated enzymes in head and neck squamous cell carcinoma and response to cisplatin-based neoadjuvant chemotherapy, INT J CANC, 93(5), 2001, pp. 725-730
Authors:
Wolkenstein, P
Loriot, MA
Aractingi, S
Cabelguenne, A
Beaune, P
Chosidow, O
Citation: P. Wolkenstein et al., Prospective evaluation of detoxification pathways as markers of cutaneous adverse reactions to sulphonamides in AIDS, PHARMACOGEN, 10(9), 2000, pp. 821-828
Authors:
Cabelguenne, A
Blons, H
de Waziers, I
Carnot, F
Houllier, AM
Soussi, T
Brasnu, D
Beaune, P
Luccourreye, O
Laurent-Puig, P
Citation: A. Cabelguenne et al., p53 alterations predict tumor response to neoadjuvant chemotherapy in headand neck squamous cell carcinoma: A prospective series, J CL ONCOL, 18(7), 2000, pp. 1465-1473
Authors:
Coulet, F
Blons, H
Cabelguenne, A
Lecomte, T
Laccourreye, O
Brasnu, D
Beaune, P
Zucman, J
Laurent-Puig, P
Citation: F. Coulet et al., Detection plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis, CANCER RES, 60(3), 2000, pp. 707-711
Authors:
Blons, H
Cabelguenne, A
Carnot, F
Laccourreye, O
de Waziers, I
Hamelin, R
Brasnu, D
Beaune, P
Laurent-Puig, P
Citation: H. Blons et al., Microsatellite analysis and response to chemotherapy in head-and-neck squamous-cell carcinoma, INT J CANC, 84(4), 1999, pp. 410-415